Clinical Guides
Silicosis
A clinically focused clinical guide to preventing, recognising and managing silicosis in India, including exposure control, tuberculosis assessment, statutory reporting, compensation pathways and the limits of available treatment.
MedNext Academy | 14 min read
Silicosis
A clinically focused clinical guide to preventing, recognising and managing silicosis in India, including exposure control, tuberculosis assessment, statutory reporting, compensation pathways and the limits of available treatment.
Summary
Silicosis is a preventable pneumoconiosis caused by inhaling respirable crystalline silica and the resulting fibrotic reaction in the lungs. Exposure occurs during drilling, crushing, cutting, grinding or polishing stone and mineral-containing materials, abrasive blasting, foundry work, ceramics, construction, tunnelling and mining. Disease may appear after years of cumulative exposure, after a shorter period of intense exposure, or rapidly after exceptionally heavy exposure. Removing exposure can prevent further dose, but established fibrosis may progress and cannot presently be reversed by a proven drug.
The diagnostic core is a sufficiently detailed lifetime occupational history plus compatible chest imaging, after considering tuberculosis and other causes of nodular or fibrotic lung disease. Spirometry measures functional impairment but does not establish the cause. The ILO system standardises description of posteroanterior chest radiographs; it is not a stand-alone diagnostic or compensation decision. Silica-exposed workers also require active attention to tuberculosis, airflow limitation, infection, hypoxaemia and disability.
Management combines complete avoidance of further silica, smoking cessation, vaccination, pulmonary rehabilitation, treatment of complications, oxygen when independently indicated, and specialist review for advanced disease. Prevention is primarily an employer and system duty: substitute safer material where feasible, suppress dust at source, use effective local exhaust and wet methods, monitor exposure, maintain equipment and provide correctly selected respiratory protection as the last layer. Indian notification and compensation routes depend on the applicable employment law, state rules and documented exposure. This draft provides education, not an individual diagnosis, legal opinion or declaration of benefit eligibility.
How Common Is It?
India has no single, current, complete national count of people with silicosis. Routine statistics under-represent workers in small units, informal stone work, migratory labour, construction and unregistered mines; diagnosis may be missed or recorded as tuberculosis or another chronic respiratory disease. DGFASLI and DGMS documents nevertheless identify silicosis as a persistent occupational-health problem in factories and mines. Local cluster reports and compensation registers cannot be extrapolated into a national prevalence because exposure intensity, workforce turnover, surveillance coverage and diagnostic standards vary widely.
Risk is concentrated rather than evenly distributed. Stone quarrying and crushing, engineered or natural stone fabrication, sandstone work, slate and agate processing, tunnelling, mining, foundries, pottery, refractory manufacture, abrasive blasting and dusty construction tasks can generate respirable crystalline silica. Workers who drill or dry-cut in confined or poorly ventilated areas may receive a large dose quickly. People living near uncontrolled dust sources can also be exposed, although an occupational diagnosis still requires careful reconstruction of source and intensity.
Surveillance data must be interpreted with a denominator: the number examined, job categories, duration, dust measurements, imaging method and reader quality. A low number of notified cases may mean effective control, but it may instead reflect weak access or under-recognition. Conversely, a screening chest radiograph labelled abnormal is not a confirmed clinical case. Programmes should report exposure measurements, suspected and confirmed disease, tuberculosis evaluation, job removal, follow-up and compensation outcomes separately. The practical clinical message is to ask every person with chronic respiratory symptoms where and how they have worked, including temporary, subcontracted and home-based work.
Risk Factors
Cumulative inhaled dose is the main determinant: airborne concentration, crystalline silica content, particle size, hours per shift, years exposed and effectiveness of controls all matter. High-intensity dry drilling, cutting, crushing or blasting can be dangerous even when employment has been brief. Enclosed spaces, poor ventilation, visible dust clouds, compressed-air cleaning, dry sweeping, damaged extraction, badly fitting respirators and production-linked pressure increase exposure. A job title alone is inadequate because two workers in the same trade may perform very different tasks.
Take a task-by-task history covering every employer and informal job, materials handled, dry or wet process, power tools, enclosure, local exhaust, respiratory protective equipment, fit testing, air monitoring, co-workers with disease and dates. Record migration and subcontracting without assuming that absence of payslips disproves exposure. Smoking does not cause silicosis, but it adds airflow obstruction, cardiovascular risk and lung-cancer risk. Previous tuberculosis can mimic radiographic disease, while silicosis itself increases susceptibility to active tuberculosis. Autoimmune disease and chronic kidney disease have also been associated with silica exposure, although an individual association should not be asserted without clinical evidence.
Preventive hierarchy matters more than personal behaviour. Eliminate or substitute silica-containing material where practicable; isolate the process; use wet methods and local exhaust close to generation; maintain and verify engineering controls; restrict access; clean by wet or suitable vacuum methods; and monitor airborne respirable dust. Respirators supplement rather than replace these controls and must match the hazard, fit the worker and be maintained. Periodic symptom review, lung function and appropriately governed imaging can detect harm, but surveillance is not a licence to continue uncontrolled exposure. Workers must receive understandable risk information and a safe route to report symptoms without retaliation.
Diagnosis
History
Ask about exertional breathlessness, persistent cough, sputum, chest tightness, fatigue, weight loss, fever, night sweats and haemoptysis. Establish onset and progression, then reconstruct lifetime work chronologically: task, material, location, hours, years, wet or dry method, enclosure, ventilation, respiratory protection and known dust measurements. Include construction, quarry, mine, stone fabrication, foundry, ceramic, refractory and abrasive work, even if seasonal or informal. Ask about tuberculosis exposure and treatment, smoking, biomass smoke, autoimmune symptoms and prior chest imaging. Symptoms can be absent despite radiographic disease and cannot grade exposure reliably.
Examination
Record respiratory rate, oxygen saturation at rest and after appropriate exertion, work of breathing, body mass and signs of chronic respiratory failure. Auscultation may be normal or reveal crackles or wheeze; neither finding confirms silicosis. Look for clubbing, lymphadenopathy, right-heart strain and connective-tissue features because they broaden the differential. Fever, focal chest signs or wasting demand prompt investigation for tuberculosis or infection. Examination should also document functional ability and safe work capacity without converting one clinic encounter into a final disability percentage.
Investigations
Obtain a good-quality posteroanterior chest radiograph and compare earlier films. A trained reader may use the ILO 2022 Classification to record small-opacity profusion, size and shape, large opacities, pleural findings and technical quality. The classification describes images; it does not prove causation. High-resolution CT can clarify equivocal radiographs, complications or alternative diagnoses, but should not become indiscriminate screening. Perform spirometry with quality checks, lung volumes or diffusion capacity when available, and exertional oxygen assessment when relevant. Evaluate tuberculosis according to current NTEP or WHO diagnostic pathways using microbiological tests rather than radiology alone. Bronchoscopy, lavage, biopsy, autoimmune tests and cardiac assessment are reserved for specific uncertainty or complications.
Differential Diagnosis
Tuberculosis is the most consequential alternative and frequent coexisting disease in India. Upper-zone nodules, fibrosis, cavitation, lymph-node enlargement and constitutional symptoms may occur in either condition; a radiograph cannot safely distinguish active infection. Seek microbiological evidence with an appropriate respiratory specimen and molecular test, culture or additional sampling under the current programme pathway. A previous course of antitubercular therapy does not prove the original diagnosis, and a new positive test does not erase underlying occupational fibrosis.
Other pneumoconioses include coal mine dust lung disease, mixed-dust fibrosis and asbestosis. Exposure history separates them better than a generic label of dusty work. Sarcoidosis can produce perilymphatic nodules and hilar adenopathy; chronic hypersensitivity pneumonitis, idiopathic or connective-tissue-disease interstitial lung disease and healed granulomatous infection can cause fibrosis. Progressive massive fibrosis can resemble malignancy, while rheumatoid nodules, fungal infection and metastatic disease enter the differential according to clinical context. Emphysema or chronic bronchitis may account for disproportionate obstruction.
Acute silicoproteinosis after intense exposure can present over weeks or months with dyspnoea, hypoxaemia and alveolar filling rather than the classic chronic nodular picture. Cardiogenic pulmonary oedema, infection and pulmonary alveolar proteinosis from other causes must be considered. Histology showing birefringent particles or silicotic nodules may support diagnosis, but biopsy is not routine when exposure and imaging are convincing because sampling carries risk and does not quantify entitlement. The correct conclusion may be mixed disease: silicosis with tuberculosis, COPD, infection or cardiac failure. Diagnostic confidence should state what evidence exists, what remains uncertain and which dangerous alternatives have been actively excluded.
Management
Stop further respirable crystalline silica exposure immediately while occupational and employer processes are reviewed. This is exposure removal, not dismissal: clinicians should document restrictions and involve occupational-health, labour or social-support services so the worker is not forced back into the same hazardous task without controls. Established silicotic fibrosis has no proven curative medicine. Follow symptoms, oxygenation, lung function and imaging at a clinically justified interval; repeated CT without a decision purpose adds radiation and cost.
Offer smoking cessation and vaccinations according to the current national or local schedule. Pulmonary rehabilitation, graded activity, breathing strategies, nutrition and management of anxiety can improve function even when fibrosis persists. Treat demonstrable airflow obstruction with inhaled therapy under usual COPD or asthma principles rather than prescribing bronchodilators automatically. Oxygen is used only after documented hypoxaemia under an applicable protocol. Manage bacterial infection, heart failure, pulmonary hypertension and other complications on their merits. Long-term systemic corticosteroids or antifibrotic drugs are not established routine treatment for chronic silicosis.
Evaluate cough, fever, weight loss, radiographic change or clinical deterioration promptly for tuberculosis. Preventive or active TB therapy must follow current programme testing, resistance assessment, drug interaction and monitoring standards; silicosis is not a reason to improvise a regimen. Acute silicoproteinosis may prompt specialist consideration of whole-lung lavage, but evidence is limited and access is highly specialised. Refer advanced, progressive disease for interstitial-lung-disease and transplant assessment where suitable, acknowledging availability, cost and eligibility constraints. Parallel management should preserve exposure records, surveillance results and work documentation needed for notification, disability assessment or compensation, with the worker's consent.
Prescribing Information
No drug removes retained silica or reverses established fibrosis. Avoid presenting corticosteroids, immunosuppressants, antifibrotics, herbal preparations, chelation or repeated antibiotics as a cure. A bronchodilator may help when spirometry and symptoms show an obstructive component; select the inhaler, dose and device according to diagnosis, technique, affordability and current formulary. Inhaled corticosteroids require a separate indication and can increase infection risk. Pulmonary rehabilitation and exposure cessation should not be displaced by a prescription pad.
Tuberculosis management is the highest-stakes prescribing issue. Obtain programme-recommended microbiological testing, assess prior treatment and drug resistance, and use the current NTEP regimen rather than empirical prolonged monotherapy. Check weight, renal and hepatic function, pregnancy potential, HIV status where consented, interacting medicines and adherence barriers. Rifampicin changes the exposure of many medicines; isoniazid, pyrazinamide and other agents require toxicity monitoring. The exact preventive-treatment approach for a person with silicosis but no active TB must follow current national eligibility and exclusion criteria, because recommendations and available regimens evolve.
Give influenza, pneumococcal, COVID-19 and other vaccines only according to current age, risk and national or local guidance; this guide does not prescribe a universal product schedule. Long-term oxygen requires objective qualification, safe equipment and fire-risk counselling. Opioids for refractory breathlessness and transplant-related medicines belong to specialist palliative or advanced-lung-disease care. Record adverse reactions and occupational implications of sedating drugs. If a proprietary supplement or 'lung cleansing' product is offered, explain that symptom testimonials are not evidence of silica clearance. Every medicine should have a named indication, monitoring plan, stop or review point and affordable access route.
When to Refer
Refer a worker with compatible exposure and an abnormal chest radiograph, unexplained breathlessness, declining spirometry or suspected occupational disease to a respiratory or occupational-medicine service. The referral should include a chronological task history, employer and worksite details where known, exposure controls, dust-monitoring records if available, previous radiographs, lung-function quality, smoking and biomass history, and tuberculosis results. Specialist assessment should correlate clinical findings, investigations and occupational history rather than deciding from a film label; mining cases may also require the relevant DGMS-linked pathway.
Use urgent hospital referral for hypoxaemia, respiratory distress, haemoptysis, suspected active tuberculosis with instability, pneumothorax, severe infection, acute right-heart failure or rapid deterioration. A patient with subacute heavy-exposure illness and diffuse alveolar change needs specialist assessment for acute silicoproteinosis. Interstitial-lung-disease or transplant referral is appropriate for progressive physiological impairment despite exposure cessation, but should not delay symptom control or social support.
Occupational referral is separate from clinical treatment. Where the applicable law requires notification, the responsible medical practitioner or certifying authority should use the correct statutory route and preserve confidentiality. A worker seeking benefits may need the Employees' Compensation authority, Employees' State Insurance pathway, a state silicosis board or welfare scheme, depending on coverage and location. Do not promise eligibility or a fixed award. Help obtain certified exposure and employment evidence, diagnostic records and disability assessment, and consider legal-aid or worker-support referral. People in informal work often lack documents; record their account carefully rather than denying evaluation at the first barrier.
Red Flags
Severe breathlessness at rest, cyanosis, new confusion, exhaustion, inability to speak normally, low oxygen saturation, hypotension or rapidly increasing respiratory rate requires emergency assessment. Sudden pleuritic pain or unilateral reduction in breath sounds may indicate pneumothorax. Haemoptysis may reflect tuberculosis, bronchiectasis, malignancy or infection and should not be attributed automatically to fibrosis. Fever, night sweats, weight loss, new cavity or radiographic progression requires active tuberculosis investigation and infection-control precautions appropriate to the setting.
A marked fall in exercise capacity, new peripheral oedema, raised jugular venous pressure or syncope can signal pulmonary hypertension or right-heart failure. Progressive massive fibrosis may distort airways and vessels, but acute deterioration still requires a search for infection, embolism, cardiac disease and pneumothorax. In a recently heavily exposed worker, rapidly progressive dyspnoea, diffuse ground-glass or alveolar opacities and hypoxaemia suggest acute silicoproteinosis and warrant tertiary review.
Occupational and social warning signs also matter. Continued dry cutting or blasting in visible dust after diagnosis, shared or unfit respirators, absent water suppression, compressed-air cleaning, lack of medical surveillance or threats following symptom reporting indicate ongoing preventable harm. Do not return a worker to uncontrolled exposure because symptoms are mild or a radiograph is unchanged. Loss of wages, migration, language barriers and inability to obtain records can interrupt both care and compensation. A suspected cluster among co-workers should trigger competent occupational-health and regulatory assessment rather than informal screening without consent, quality assurance, referral capacity and a plan for abnormal results.
Indian Clinical Context
DGFASLI materials place silica control within the Factories Act framework: Section 14 addresses dust and fumes, Section 87 supports special rules for dangerous operations, and the Third Schedule includes silicosis among notifiable diseases. Model provisions cited by DGFASLI emphasise enclosure or suppression, exhaust near the source, wet cleaning, medical examination, worker education and respiratory protection. Mines have separate DGMS oversight and occupational-health surveillance. The Occupational Safety, Health and Working Conditions Code, 2020 and associated rules create a changing transition; clinicians and employers must verify commencement, current central and state provisions, and which inspectorate has jurisdiction rather than treating an old summary as current legal advice.
The Employees' Compensation Act lists pneumoconioses caused by sclerogenic mineral dust, including silicosis and silicotuberculosis where silicosis is an essential factor in incapacity or death, in Schedule III Part C. That listing does not make every claim automatic. Covered employment, occupational exposure, diagnosis, causation, incapacity, procedure and limitation issues require assessment under the law actually applicable. ESI coverage and state relief or rehabilitation schemes may provide different routes. Never quote a universal compensation amount; state policies and court or commission directions change.
Informal and migrant workers often cross regulatory categories and may have no continuous payroll record. A clinically useful file preserves self-reported worksites, co-worker contacts, photographs or job cards where voluntarily supplied, dates, radiographs, spirometry and microbiology without altering facts to fit a claim. Prevention must extend beyond issuing masks: employers control material choice, process design, extraction, water, housekeeping and production systems. Medical surveillance without exposure reduction detects injury after prevention has failed. Workers need counselling in an understood language, continuity for tuberculosis care and a realistic route to occupational, social-welfare and legal support.
NMC Competency Mapping
Silicosis integrates Community Medicine occupational-health competencies with respiratory medicine, pathology, radiology, microbiology and forensic or medico-legal learning. Using the 2024 NMC curriculum as a framework, the learner should identify occupational hazards, take a complete work history, explain prevention through the hierarchy of controls, recognise an occupational disease, communicate risk and understand notification, rehabilitation and compensation principles. Mapping is educational: it does not qualify a student to certify pneumoconiosis, determine disability or give legal advice.
Clinical competence includes distinguishing exposure from disease, recognising chronic, accelerated and acute presentations, measuring oxygenation and lung function, and interpreting a radiology report in context. Learners should know that upper-zone small rounded opacities, hilar-node 'eggshell' calcification and progressive massive fibrosis are classic associations but neither sensitive nor pathognomonic. The ILO Classification standardises description of posteroanterior radiographs for surveillance and comparison; diagnosis still requires exposure correlation and differential assessment. Tuberculosis must be tested microbiologically because symptoms and cavities overlap.
Prevention competence requires more than recalling personal protective equipment. Learners should order controls conceptually as elimination or substitution, isolation and engineering suppression, administrative systems and properly selected respiratory protection. They should explain why dry sweeping and compressed-air cleaning can re-aerosolise fine dust. Professional competence includes documenting honestly, protecting confidentiality, arranging urgent care, following current statutory notification and supporting access for informal workers. Examination questions may test named statutes, but real practice requires checking current commencement, amended state rules and jurisdiction. A learner should state evidence limits and avoid promising that treatment, transplantation or compensation is universally available.
Key Exam Pearls for NEET PG
Crystalline silica activates alveolar macrophages and drives nodular fibrosis, classically with upper-zone predominance. Chronic silicosis follows cumulative exposure over years; accelerated disease follows heavier exposure over a shorter period; acute silicoproteinosis can follow extreme exposure and resembles alveolar proteinosis. Radiographic clues include multiple small rounded opacities, coalescence into progressive massive fibrosis and peripheral 'eggshell' calcification of hilar nodes. These are memorable patterns, not substitutes for a work history or microbiological testing.
Silicosis substantially increases tuberculosis risk. Fever, weight loss, haemoptysis, a new cavity or deterioration demands active TB evaluation; do not diagnose silicotuberculosis from an X-ray alone. Spirometry may show restriction, obstruction or a mixed pattern and grades physiology rather than aetiology. The ILO 2022 radiograph system records technical quality, small-opacity profusion, shape and size, large opacities and pleural findings using standards. It is not itself a diagnostic threshold or disability award.
There is no proven medicine that removes silica or reverses established chronic fibrosis. The pivotal intervention is preventing further exposure, then treating airflow obstruction, infection, hypoxaemia and other complications, using rehabilitation and considering transplantation in selected advanced disease. Prevention follows the hierarchy of controls; a respirator is not a substitute for dust suppression and extraction. In Indian law questions, remember silicosis in the Factories Act Third Schedule and pneumoconiosis or silicotuberculosis in Schedule III Part C of the Employees' Compensation Act, but in clinical practice verify the current legal regime and state pathway before advising a worker.
Frequently Asked Questions
Can a normal chest radiograph rule out harmful silica exposure or early silicosis?
No. A normal film does not show that exposure was safe, and early disease may be radiographically inapparent. Reconstruct the task and controls, obtain quality-assured spirometry and use surveillance or specialist imaging according to risk and symptoms. High-resolution CT can clarify selected cases but is not a harmless mass-screening substitute for exposure control.
Does a worker with silicosis automatically have tuberculosis as well?
No, but the risk of active tuberculosis is materially increased and the presentations overlap. Fever, weight loss, haemoptysis, cavitation or deterioration needs prompt programme-aligned microbiological testing. Neither a suggestive X-ray nor improvement during empirical treatment proves coexisting TB, and confirmed TB does not remove the need to address occupational fibrosis.
Is an N95-style respirator enough to make silica-generating work safe?
Not by itself. Prevention starts by eliminating or substituting the hazard, enclosing the process, applying effective wet suppression and local exhaust, maintaining equipment, controlling access and cleaning safely. Respiratory protection is an additional layer that requires hazard-based selection, fit testing, correct use and replacement; visible uncontrolled dust signals a system failure.
Does a diagnosis of silicosis guarantee compensation anywhere in India?
No. Silicosis and relevant pneumoconioses appear in Indian occupational-disease schedules, but the applicable route depends on employment coverage, jurisdiction, exposure evidence, diagnosis, disability and current central or state rules. Preserve records and seek competent occupational-health, welfare or legal support. A clinical guide cannot promise eligibility, timing or a fixed payment.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic